StonvexLoading…
StonvexCore line items from TEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.73B | $5.42B | $4.10B | $2.72B |
Operating Income | $-82.00M | $475.00M | $338.00M | $198.00M |
Net Income | $-89.00M | $221.00M | $158.00M | $93.00M |
EPS (Diluted) | $-0.93 | $3.33 | $2.38 | $1.40 |
Total Assets | $10.19B | $6.14B | $6.17B | $6.15B |
Total Liabilities | $5.37B | $4.04B | $4.15B | $4.19B |
Cash & Equivalents | $392.00M | $772.00M | $509.00M | $374.00M |
Free Cash Flow OCF − CapEx | $-57.00M | $322.00M | $151.00M | $21.00M |
Shares Outstanding | 96.10M | 66.30M | 66.40M | 66.50M |